Allowing gene patents could be an expensive mistake for the US

Michel, Hartmut

doi:10.1038/35030194

Local TagsRelease HistoryDetailsSummary

Allowing gene patents could be an expensive mistake for the US

Michel, H. (2000). Allowing gene patents could be an expensive mistake for the US. Nature, 407, 285-285. doi:10.1038/35030194.

Item is Released

show all

Basic

hide

Item Permalink: https://hdl.handle.net/21.11116/0000-0007-1295-C Version Permalink: https://hdl.handle.net/21.11116/0000-000B-A25B-8

Genre: Journal Article

Files

show Files

Locators

show

Creators

hide

Creators:
Michel, Hartmut¹, Author

Affiliations:
1Department of Molecular Membrane Biology, Max Planck Institute of Biophysics, Max Planck Society, ou_2068290

Content

hide

Free keywords: -

Abstract: Sir — In the discussion of gene patents1, it is generally overlooked that these primarily aim at the encoded protein and not the gene. The discoverers try to patent the use of the ‘gene product’ either as a therapeutic protein, or as an intervention point (‘drug target’) to treat a disease.

Details

hide

Language(s): eng - English

Dates: Date issued: 2000-09-21

Publication Status: Issued

Pages: 1

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: DOI: 10.1038/35030194

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

hide

Title: Nature

Abbreviation : Nature

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: Nature Publishing Group

Pages: - Volume / Issue: 407 Sequence Number: - Start / End Page: 285 - 285 Identifier: ISSN: 0028-0836
CoNE: https://pure.mpg.de/cone/journals/resource/954925427238